Proactiveinvestors United Kingdom Alnylam Pharmaceuticals https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Alnylam Pharmaceuticals RSS feed en Sun, 08 Dec 2019 14:29:42 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Bitcoin Pre-Halvening Dump Could Spell Disaster https://www.proactiveinvestors.co.uk/companies/news/907974/bitcoin-pre-halvening-dump-could-spell-disaster-907974.html Wed, 27 Nov 2019 09:35:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/907974/bitcoin-pre-halvening-dump-could-spell-disaster-907974.html Alnylam Pharmaceuticals, American Express Company, Abbott Laboratories and more https://www.proactiveinvestors.co.uk/companies/news/185806/alnylam-pharmaceuticals-american-express-company-abbott-laboratories-and-more-185806.html Wed, 18 Oct 2017 16:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/185806/alnylam-pharmaceuticals-american-express-company-abbott-laboratories-and-more-185806.html Alnylam heads higher as it strikes US$1bn-plus licencing deal with Vir Biotechnology https://www.proactiveinvestors.co.uk/companies/news/185816/alnylam-heads-higher-as-it-strikes-us1bn-plus-licencing-deal-with-vir-biotechnology-185816.html Wed, 18 Oct 2017 13:02:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/185816/alnylam-heads-higher-as-it-strikes-us1bn-plus-licencing-deal-with-vir-biotechnology-185816.html Alnylam Pharma's shares leap as it reveals positive results from late-stage trial for a hereditary disease treatment https://www.proactiveinvestors.co.uk/companies/news/184308/alnylam-pharma-s-shares-leap-as-it-reveals-positive-results-from-late-stage-trial-for-a-hereditary-disease-treatment-184308.html Wed, 20 Sep 2017 16:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/184308/alnylam-pharma-s-shares-leap-as-it-reveals-positive-results-from-late-stage-trial-for-a-hereditary-disease-treatment-184308.html Alnylam Pharmaceuticals suspends all treatment with its fitusiran haemophilia product after a trial patient dies https://www.proactiveinvestors.co.uk/companies/news/183606/alnylam-pharmaceuticals-suspends-all-treatment-with-its-fitusiran-haemophilia-product-after-a-trial-patient-dies-183606.html Thu, 07 Sep 2017 15:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/183606/alnylam-pharmaceuticals-suspends-all-treatment-with-its-fitusiran-haemophilia-product-after-a-trial-patient-dies-183606.html Alnylam shares plunge after it stops development of resuviran https://www.proactiveinvestors.co.uk/companies/news/167034/alnylam-shares-plunge-after-it-stops-development-of-resuviran-167034.html Thu, 06 Oct 2016 14:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167034/alnylam-shares-plunge-after-it-stops-development-of-resuviran-167034.html Alnylam Pharma shares advance on positive gene-therapy trial results https://www.proactiveinvestors.co.uk/companies/news/87909/alnylam-pharma-shares-advance-on-positive-gene-therapy-trial-results-31999.html Mon, 16 Jul 2012 15:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/87909/alnylam-pharma-shares-advance-on-positive-gene-therapy-trial-results-31999.html Alnylam shares rally on phase 1 cholesterol-lowering drug results https://www.proactiveinvestors.co.uk/companies/news/85544/alnylam-shares-rally-on-phase-1-cholesterol-lowering-drug-results--28028.html Fri, 20 Apr 2012 18:14:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/85544/alnylam-shares-rally-on-phase-1-cholesterol-lowering-drug-results--28028.html Alnylam boasts positive preliminary results from phase 1 study for RNAi treatment https://www.proactiveinvestors.co.uk/companies/news/81590/alnylam-boasts-positive-preliminary-results-from-phase-1-study-for-rnai-treatment--21384.html Mon, 21 Nov 2011 16:06:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/81590/alnylam-boasts-positive-preliminary-results-from-phase-1-study-for-rnai-treatment--21384.html